HSBC Holdings’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $142M | Sell |
1,770,962
-378,012
| -18% | -$31.2M | 0.07% | 255 |
|
|
2025
Q4 | $183M | Sell |
2,148,974
-41,623
| -2% | -$3.42M | 0.09% | 197 |
|
|
2025
Q3 | $170M | Buy |
2,190,597
+356,863
| +19% | +$27.9M | 0.09% | 197 |
|
|
2025
Q2 | $143M | Sell |
1,833,734
-137,002
| -7% | -$10.2M | 0.09% | 225 |
|
|
2025
Q1 | $143M | Sell |
1,970,736
-3,549
| -0.2% | -$254K | 0.09% | 218 |
|
|
2024
Q4 | $146M | Sell |
1,974,285
-168,858
| -8% | -$11.8M | 0.09% | 220 |
|
|
2024
Q3 | $141M | Buy |
2,143,143
+296,688
| +16% | +$21.6M | 0.08% | 226 |
|
|
2024
Q2 | $171M | Buy |
1,846,455
+70,210
| +4% | +$6.22M | 0.1% | 169 |
|
|
2024
Q1 | $170M | Buy |
1,776,245
+159,276
| +10% | +$13.4M | 0.11% | 160 |
|
|
2023
Q4 | $123M | Buy |
1,616,969
+393,297
| +32% | +$27.4M | 0.11% | 173 |
|
|
2023
Q3 | $84.8M | Buy |
1,223,672
+899
| +0.1% | +$72.2K | 0.09% | 220 |
|
|
2023
Q2 | $115M | Sell |
1,222,773
-504,470
| -29% | -$43.8M | 0.12% | 160 |
|
|
2023
Q1 | $142M | Buy |
1,727,243
+370,785
| +27% | +$29.1M | 0.17% | 111 |
|
|
2022
Q4 | $101M | Buy |
1,356,458
+542,600
| +67% | +$41.8M | 0.12% | 169 |
|
|
2022
Q3 | $67.8M | Buy |
813,858
+42,754
| +6% | +$4.11M | 0.11% | 165 |
|
|
2022
Q2 | $73.7M | Sell |
771,104
-69,974
| -8% | -$7.24M | 0.1% | 173 |
|
|
2022
Q1 | $99M | Sell |
841,078
-62,888
| -7% | -$7.05M | 0.12% | 144 |
|
|
2021
Q4 | $117M | Sell |
903,966
-51,715
| -5% | -$6.03M | 0.11% | 160 |
|
|
2021
Q3 | $108M | Sell |
955,681
-52,995
| -5% | -$6.05M | 0.11% | 152 |
|
|
2021
Q2 | $105M | Sell |
1,008,676
-37,806
| -4% | -$3.56M | 0.11% | 163 |
|
|
2021
Q1 | $87.4M | Buy |
1,046,482
+22,836
| +2% | +$1.93M | 0.1% | 187 |
|
|
2020
Q4 | $92.9M | Buy |
1,023,646
+125,669
| +14% | +$10.4M | 0.12% | 156 |
|
|
2020
Q3 | $71.6M | Buy |
897,977
+135,684
| +18% | +$10.6M | 0.11% | 149 |
|
|
2020
Q2 | $52.7M | Buy |
762,293
+162,131
| +27% | +$11.5M | 0.1% | 176 |
|
|
2020
Q1 | $38.3M | Buy |
600,162
+81,654
| +16% | +$5.89M | 0.09% | 207 |
|
|
2019
Q4 | $40.6M | Buy |
518,508
+123,648
| +31% | +$9.66M | 0.07% | 282 |
|
|
2019
Q3 | $28.9M | Sell |
394,860
-4,536
| -1% | -$319K | 0.05% | 383 |
|
|
2019
Q2 | $24.6M | Sell |
399,396
-38,133
| -9% | -$2.31M | 0.05% | 420 |
|
|
2019
Q1 | $27.9M | Buy |
437,529
+70,950
| +19% | +$4.05M | 0.05% | 376 |
|
|
2018
Q4 | $18.7M | Sell |
366,579
-91,056
| -20% | -$4.61M | 0.03% | 526 |
|
|
2018
Q3 | $26.6M | Sell |
457,635
-107,019
| -19% | -$5.23M | 0.04% | 444 |
|
|
2018
Q2 | $27.4M | Sell |
564,654
-226,044
| -29% | -$10.6M | 0.05% | 388 |
|
|
2018
Q1 | $36.8M | Buy |
790,698
+127,890
| +19% | +$5.55M | 0.05% | 336 |
|
|
2017
Q4 | $24.9M | Sell |
662,808
-196,071
| -23% | -$7.2M | 0.04% | 427 |
|
|
2017
Q3 | $31.3M | Buy |
858,879
+155,073
| +22% | +$5.91M | 0.05% | 386 |
|
|
2017
Q2 | $27.7M | Buy |
703,806
+128,154
| +22% | +$4.68M | 0.05% | 403 |
|
|
2017
Q1 | $18M | Buy |
575,652
+70,485
| +14% | +$2.21M | 0.04% | 501 |
|
|
2016
Q4 | $15.8M | Buy |
505,167
+71,865
| +17% | +$2.33M | 0.04% | 551 |
|
|
2016
Q3 | $17.4M | Sell |
433,302
-873
| -0.2% | -$32.9K | 0.04% | 473 |
|
|
2016
Q2 | $14.4M | Buy |
434,175
+16,743
| +4% | +$573K | 0.04% | 530 |
|
|
2016
Q1 | $12.3M | Sell |
417,432
-586,335
| -58% | -$16.2M | 0.03% | 563 |
|
|
2015
Q4 | $26.4M | Buy |
1,003,767
+497,379
| +98% | +$12.9M | 0.06% | 354 |
|
|
2015
Q3 | $12M | Sell |
506,388
-121,218
| -19% | -$2.93M | 0.03% | 545 |
|
|
2015
Q2 | $14.9M | Sell |
627,606
-14,910
| -2% | -$336K | 0.03% | 508 |
|
|
2015
Q1 | $15.3M | Buy |
642,516
+35,898
| +6% | +$805K | 0.03% | 525 |
|
|
2014
Q4 | $12.9M | Buy |
606,618
+82,626
| +16% | +$1.66M | 0.03% | 583 |
|
|
2014
Q3 | $8.93M | Buy |
523,992
+39,486
| +8% | +$623K | 0.02% | 695 |
|
|
2014
Q2 | $6.95M | Buy |
484,506
+20,334
| +4% | +$276K | 0.02% | 736 |
|
|
2014
Q1 | $5.7M | Buy |
464,172
+51,900
| +13% | +$599K | 0.01% | 759 |
|
|
2013
Q4 | $4.52M | Sell |
412,272
-44,958
| -10% | -$507K | 0.01% | 879 |
|
|
2013
Q3 | $5.3M | Buy |
457,230
+111,552
| +32% | +$1.31M | 0.01% | 832 |
|
|
2013
Q2 | $3.87M | Buy |
+345,678
| New | +$4.09M | 0.01% | 759 |
|
Other funds holding EW
VCM
VPM
HSBC Holdings's EW Position: Q1 2026 in Review
HSBC Holdings reduced its Edwards Lifesciences (EW) stake by 18% in Q1 2026, selling an estimated $31.2M and leaving 1,770,962 shares worth $142M. The position accounts for 0.07% of the portfolio, ranked #255.
HSBC Holdings first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $183M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- HSBC Holdings held 1,770,962 shares of Edwards Lifesciences worth $142M as of Q1 2026.
- HSBC Holdings sold 378,012 Edwards Lifesciences shares in Q1 2026, an estimated $31.2M.
- Edwards Lifesciences made up 0.07% of HSBC Holdings's portfolio in Q1 2026, its #255 holding.
- HSBC Holdings first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Edwards Lifesciences position peaked at $183M in Q4 2025.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.